Skip to main navigation Skip to search Skip to main content

Bordetella holmesii meningitis in an asplenic patient with systemic lupus erythematosus

  • Dan M. Livovsky
  • , David Leibowitz
  • , Carlos Hidalgo-Grass
  • , Violeta Temper
  • , Shaden Salameh
  • , Maya Korem

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Bordetella holmesii is a slow-growing, Gram-negative, non-oxidizing bacillus with colonies that produce a brown soluble pigment and was originally described by Weyant et al. (1995) as CDC nonoxidizer group 2 (NO-2). It has recently been shown that B. holmesii may be isolated from nasopharyngeal specimens of up to 20% of patients with pertussis-like symptoms. However, invasive B. holmesii has rarely been reported and in the vast majority of cases the patients were immune deficient, mostly as a result of splenectomy or functional asplenia. Clinical presentations have included endocarditis, pneumonia, cellulitis, suppurative arthritis, pyelonephritis and septicaemia but no previous reports have documented meningitis secondary to this organism. Here we report what we believe to be the first clinical description of an adult with B. holmesii meningitis and bacteraemia with a brief review of published cases.

Original languageEnglish
Pages (from-to)1165-1167
Number of pages3
JournalJournal of Medical Microbiology
Volume61
Issue number8
DOIs
StatePublished - Aug 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Bordetella holmesii meningitis in an asplenic patient with systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this